CooperCompanies to Present at the J.P. Morgan Healthcare Conference
17 Dicembre 2024 - 10:15PM
CooperCompanies (Nasdaq: COO), a leading medical device company,
today announced it will participate at the J.P. Morgan Healthcare
Conference on Tuesday, January 14, 2025. Al White, President and
CEO, will represent the Company in a session scheduled to begin at
6:00 PM ET.
A live and archived webcast of this event, where applicable,
will be available by accessing the CooperCompanies’ website at
http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device
company focused on improving lives one person at a time. The
Company operates through two business units, CooperVision and
CooperSurgical. CooperVision is a trusted leader in the contact
lens industry, improving the vision of millions of people every
day. CooperSurgical is a leading fertility and women’s health
company dedicated to assisting women, babies and families at the
healthcare moments that matter most. Headquartered in San Ramon,
CA, CooperCompanies (“Cooper”) has a workforce of more than 16,000
with products sold in over 130 countries. For more information,
please visit www.coopercos.com.
Contact:
Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Grafico Azioni Cooper Companies (NASDAQ:COO)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Cooper Companies (NASDAQ:COO)
Storico
Da Dic 2023 a Dic 2024